PL449412A1 - Krystaliczna forma kompleksu poli-[bis(6-bromo-imidazo[1,2-a]pirydyna)mangan(II)-(μ2-chinolina-2-karboksylato-κ2N,O:κO')-bis(chinolina-2-karboksylato-κ2N,O)mangan(II)], sposób jej otrzymywania oraz jej zastosowanie - Google Patents

Krystaliczna forma kompleksu poli-[bis(6-bromo-imidazo[1,2-a]pirydyna)mangan(II)-(μ2-chinolina-2-karboksylato-κ2N,O:κO')-bis(chinolina-2-karboksylato-κ2N,O)mangan(II)], sposób jej otrzymywania oraz jej zastosowanie

Info

Publication number
PL449412A1
PL449412A1 PL449412A PL44941224A PL449412A1 PL 449412 A1 PL449412 A1 PL 449412A1 PL 449412 A PL449412 A PL 449412A PL 44941224 A PL44941224 A PL 44941224A PL 449412 A1 PL449412 A1 PL 449412A1
Authority
PL
Poland
Prior art keywords
carboxylato
quinoline
manganese
bis
imidazo
Prior art date
Application number
PL449412A
Other languages
English (en)
Inventor
Tomasz Mazur
Magdalena Malik
Olga Wesołowska
Kamila Środa-Pomianek
Original Assignee
Politechnika Wrocławska
Uniwersytet Medyczny Im. Piastów Śląskich
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Politechnika Wrocławska, Uniwersytet Medyczny Im. Piastów Śląskich filed Critical Politechnika Wrocławska
Priority to PL449412A priority Critical patent/PL449412A1/pl
Publication of PL449412A1 publication Critical patent/PL449412A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic Table
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/58—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems with hetero atoms directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Przedmiotem zgłoszenia jest krystaliczna forma kompleksu poli-[bis(6-bromo-imidazo[1,2-a]pirydyna)mangan(II)-(µ2-chinolina-2-karboksylato-ĸ2N,O:ĸO') -bis(chinolina-2-karboksylato-ĸ2N,O)mangan(II)] oraz sposób jego otrzymywania. Zgłoszenie dotyczy również zastosowania krystalicznej formy kompleksu poli-[bis(6-bromo-imidazo[1,2-a]pirydyna)mangan(II)-(µ2-chinolina-2-karboksylato-ĸ2N,O:ĸO')-bis(chinolina-2-karboksylato-ĸ2N,O)mangan(II)] jako leku o działaniu przeciwnowotworowym.
PL449412A 2024-07-30 2024-07-30 Krystaliczna forma kompleksu poli-[bis(6-bromo-imidazo[1,2-a]pirydyna)mangan(II)-(μ2-chinolina-2-karboksylato-κ2N,O:κO')-bis(chinolina-2-karboksylato-κ2N,O)mangan(II)], sposób jej otrzymywania oraz jej zastosowanie PL449412A1 (pl)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL449412A PL449412A1 (pl) 2024-07-30 2024-07-30 Krystaliczna forma kompleksu poli-[bis(6-bromo-imidazo[1,2-a]pirydyna)mangan(II)-(μ2-chinolina-2-karboksylato-κ2N,O:κO')-bis(chinolina-2-karboksylato-κ2N,O)mangan(II)], sposób jej otrzymywania oraz jej zastosowanie

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL449412A PL449412A1 (pl) 2024-07-30 2024-07-30 Krystaliczna forma kompleksu poli-[bis(6-bromo-imidazo[1,2-a]pirydyna)mangan(II)-(μ2-chinolina-2-karboksylato-κ2N,O:κO')-bis(chinolina-2-karboksylato-κ2N,O)mangan(II)], sposób jej otrzymywania oraz jej zastosowanie

Publications (1)

Publication Number Publication Date
PL449412A1 true PL449412A1 (pl) 2026-02-02

Family

ID=98605017

Family Applications (1)

Application Number Title Priority Date Filing Date
PL449412A PL449412A1 (pl) 2024-07-30 2024-07-30 Krystaliczna forma kompleksu poli-[bis(6-bromo-imidazo[1,2-a]pirydyna)mangan(II)-(μ2-chinolina-2-karboksylato-κ2N,O:κO')-bis(chinolina-2-karboksylato-κ2N,O)mangan(II)], sposób jej otrzymywania oraz jej zastosowanie

Country Status (1)

Country Link
PL (1) PL449412A1 (pl)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4096264A (en) * 1975-12-09 1978-06-20 Merck & Co., Inc. Certain substituted imidazo [1,2-a] pyridines
CA1036490A (en) * 1973-08-06 1978-08-15 Montedison S.P.A. Derivatives of quinoline-8-carboxylic acid having pesticidal action

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1036490A (en) * 1973-08-06 1978-08-15 Montedison S.P.A. Derivatives of quinoline-8-carboxylic acid having pesticidal action
US4096264A (en) * 1975-12-09 1978-06-20 Merck & Co., Inc. Certain substituted imidazo [1,2-a] pyridines

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DEEP A, BHATIA RK, KAUR R, KUMAR S, JAIN UK, SINGH H, BATRA S, KAUSHIK D, DEB PK: "Curr Top Med Chem. 2017;17(2):238-250", "IMIDAZO[1,2-A]PYRIDINE SCAFFOLD AS PROSPECTIVE THERAPEUTIC AGENTS" *
LANGNER E, JELENIEWICZ W, TURSKI WA, PLECH T.: "Pharmacol Rep. 2019 Apr;71(2):189-193", "QUINALDIC ACID INDUCES CHANGES IN THE EXPRESSION OF P53 TUMOR SUPPRESSOR BOTH ON PROTEIN AND GENE LEVEL IN COLON, CANCER LS180 CELLS" *

Similar Documents

Publication Publication Date Title
EA200870321A1 (ru) Способ получения 4-оксохинолинового соединения
EA201070072A1 (ru) ПРОИЗВОДНЫЕ 6-ЦИКЛОАМИНО-3-(ПИРИДИН-4-ИЛ)ИМИДАЗО[1,2-b]ПИРИДАЗИНА, ИХ ПОЛУЧЕНИЕ И ИХ ПРИМЕНЕНИЕ В ТЕРАПИИ
Gund et al. How many rings can share a quaternary atom?
CY1109874T1 (el) Σταθερο κρυσταλλικο αλας του 5-μεθυλο-(6s)τετραϋδροφολικου οξεος
BG108318A (en) Carboxamide-substituted phenylurea derivatives and method for the production and use thereof as medicaments
EA200300211A1 (ru) Азабициклические соединения, способ их получения и их применение в качестве лекарственных средств, в частности в качестве антибактериальных средств
EA200000700A2 (ru) НОВЫЕ β- КАРБОЛИНОВЫЕ СОЕДИНЕНИЯ, СПОСОБ ИХ ПОЛУЧЕНИЯ И ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, СОДЕРЖАЩАЯ ИХ
HUP9901752A2 (hu) Rotamáz enzim hatását gátló piperidin-karbonsav-származékok alkalmazása neurológiai aktivitás kezelésére alkalmas gyógyszerkészítmény előállítására
CA2506016A1 (en) 3-amino-piperidine derivatives and processes for their preparation
MA32249B1 (fr) Dérivés polysubstitues de 2-heteroaryl-6-phenyl-imidazo[1,2- a]pyridines, leur préparation et leur application en thérapeutique
RU2014140735A (ru) ПРОИЗВОДНЫЕ ПИРАЗОЛО[1, 5-a]ПИРИМИДИНА, КОМПОЗИЦИИ, СОДЕРЖАЩИЕ УКАЗАННЫЕ СОЕДИНЕНИЯ, И СПОСОБЫ ИХ ПРИМЕНЕНИЯ
MEP14208A (en) Quinoline and isoquinoline derivatives, method for the production thereof and use thereof as anti-inflammatory agents
WO2008096845A9 (ja) 油剤ならびにそれを含有する潤滑剤、保湿剤および外用剤
JP2020503357A5 (pl)
EA201170237A1 (ru) Производные карбаматов алкилтиазолов, их получение и их применение в терапии
RU2011108663A (ru) Способы получения метилового эфира 4-оксооктагидроиндол-1-карбоновой кислоты и ее производные
DK1594885T3 (da) Lægemiddel til vækstinhibering af tumorer
PL449412A1 (pl) Krystaliczna forma kompleksu poli-[bis(6-bromo-imidazo[1,2-a]pirydyna)mangan(II)-(μ2-chinolina-2-karboksylato-κ2N,O:κO')-bis(chinolina-2-karboksylato-κ2N,O)mangan(II)], sposób jej otrzymywania oraz jej zastosowanie
MX9303123A (es) Ciclopentano-y-penteno-beta-aminoacidos, procedimiento para su preparacion y medicamentos que los contienen.
MX2008001018A (es) Derivados de n-(arilalquil)-1h-pirrolopiridina-2-carboxamida, su preparacion y su aplicacion en terapeutica.
SI1869038T1 (sl) Substituirane 5,6,7,8-tetrahidro-imidazo(1,2-a)piridin-2-ilaminske spojine in njihova uporaba za pripravo zdravil
EA201291364A1 (ru) Производные 3,4-дигидропирроло[1,2-а]пиразин-2,8(1н)-дикарбоксамида, их получение и применение в терапии
Lai et al. Synthesis, experimental and density functional theory (DFT) studies on solubility of camptothecin derivatives
ES473754A1 (es) Procedimiento de preparacion de composiciones farmaceuticas a base de nuevas w-tiopropinamidas, y de sus sales con una base mineral y organica
EA200200663A1 (ru) НОВЫЕ СОЕДИНЕНИЯ ОКТАГИДРО-2H-ПИРИДО[1,2-α]ПИРАЗИНА, СПОСОБ ИХ ПОЛУЧЕНИЯ И ФАРМАЦЕВТИЧЕСКИЕ ПРЕПАРАТЫ, ИХ СОДЕРЖАЩИЕ